Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational Results available

Clinical Outcome Assessment of Parkinson's Disease Patients Treated With XADAGO (Safinamide)

ClinicalTrials.gov ID: NCT03944785

Public ClinicalTrials.gov record NCT03944785. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 1:50 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Observational Study to Evaluate Changes in Non-Motor Symptoms and Other Clinical Outcome Assessments of Parkinson's Disease Patients Treated With XADAGO (Safinamide)Tablets

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase IV, prospective, observational, post-marketing study designed to obtain additional data on the effect of XADAGO on motor and non-motor symptoms in Parkinson's Disease patients newly prescribed XADAGO.

Study identification

NCT ID
NCT03944785
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Supernus Pharmaceuticals, Inc.
Industry
Enrollment
164 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
30 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 29, 2017
Primary completion
Dec 22, 2019
Completion
Jan 9, 2020
Last update posted
Jun 6, 2023

2017 – 2020

United States locations

U.S. sites
30
U.S. states
19
U.S. cities
30
Facility City State ZIP Site status
Alabama Neurology Associates Homewood Alabama 35244
Movement Disorders Neurology, Inc. Bakersfield California 93312
B.E.S.T. Center of Orange County Laguna Hills California 92653
Valley Parkinson Clinic Los Gatos California 95032
UC Davis Medical Center Sacramento California 95817
Hartford Healthcare Vernon Connecticut 06066
Georgetown University Hospital Washington D.C. District of Columbia 20007
Parkinson's Disease and Movement Disorders Center of Boca Raton Boca Raton Florida 33486
Neuron Research Naples Florida 34108
Parkinson's Disease Treatment Center of SW Florida Port Charlotte Florida 33980
Sarasota Memorial Hospital Clinical Research Cener Sarasota Florida 34239
Central DuPage Hospital Winfield Illinois 60190
University of Kansas Medical Center Kansas City Kansas 66160
Baptist Health System Richmond Kentucky 40475
Southeast Neuroscience Center, LLC Gray Louisiana 70359
Lester and Cox Medical Center Springfield Missouri 65807
Neurological Associates of Long Island, PC Lake Success New York 11042
NYU Winthrop Hospital Mineola New York 11501
FryeCare Neurology Hickory North Carolina 28602
Dayton Center for Neurological Disorders Centerville Ohio 45459
The Movement Disorder Clinic of Oklahoma Tulsa Oklahoma 74137
Neurology and Stroke Associates Lititz Pennsylvania 17543
Prisma Health Greenville South Carolina 29615
Covenant Medical Group Lubbock Texas 79410
Texas Institute for Neurological Disorders Sherman Texas 75092
Houston Methodist - Sugar Land Sugar Land Texas 77479
Baylor Scott and White Health Temple Texas 76508
Inova Medical Group- Neurology I Alexandria Virginia 22311
Meridian Clinical Research, LLC Norfolk Virginia 23502
Puget Sound Neurology Tacoma Washington 98409

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03944785, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 6, 2023 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03944785 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →